PDB Short entry for 1PXV HEADER HYDROLASE 07-JUL-03 1PXV TITLE THE STAPHOSTATIN-STAPHOPAIN COMPLEX: A FORWARD BINDING INHIBITOR IN TITLE 2 COMPLEX WITH ITS TARGET CYSTEINE PROTEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTEINE PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.22.-; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYSTEINE PROTEASE INHIBITOR; COMPND 9 CHAIN: C, D; COMPND 10 EC: 3.4.22.-; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 1280; SOURCE 4 GENE: STAPHOPAIN B; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: E. COLI BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PET15; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 11 ORGANISM_TAXID: 1280; SOURCE 12 GENE: STAPHOSTATIN B; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 EXPRESSION_SYSTEM_STRAIN: E. COLI BL21 (DE3)[PLYSS]; SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: PGEX-5T KEYWDS CYSTEINE PROTEASE INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR R.FILIPEK,M.RZYCHON,A.OLEKSY,M.GRUCA,A.DUBIN,J.POTEMPA,M.BOCHTLER REVDAT 5 16-AUG-23 1PXV 1 REMARK REVDAT 4 27-OCT-21 1PXV 1 REMARK SEQADV REVDAT 3 24-FEB-09 1PXV 1 VERSN REVDAT 2 23-NOV-04 1PXV 1 COMPND MASTER REVDAT 1 21-OCT-03 1PXV 0 JRNL AUTH R.FILIPEK,M.RZYCHON,A.OLEKSY,M.GRUCA,A.DUBIN,J.POTEMPA, JRNL AUTH 2 M.BOCHTLER JRNL TITL THE STAPHOSTATIN-STAPHOPAIN COMPLEX: A FORWARD BINDING JRNL TITL 2 INHIBITOR IN COMPLEX WITH ITS TARGET CYSTEINE PROTEASE. JRNL REF J.BIOL.CHEM. V. 278 40959 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12874290 JRNL DOI 10.1074/JBC.M302926200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.RZYCHON,R.FILIPEK,A.SABAT,K.KOSOWSKA,A.DUBIN,J.POTEMPA, REMARK 1 AUTH 2 M.BOCHTLER REMARK 1 TITL STAPHOSTATINS RESEMBLE LIPOCALINS, NOT CYSTATINS IN FOLD. REMARK 1 REF PROTEIN SCI. V. 12 2252 2003 REMARK 1 REFN ISSN 0961-8368 REMARK 1 DOI 10.1110/PS.03247703 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.RZYCHON,A.SABAT,K.KOSOWSKA,J.POTEMPA,A.DUBIN REMARK 1 TITL STAPHOSTATINS: AN EXPANDING NEW GROUP OF PROTEINASE REMARK 1 TITL 2 INHIBITORS WITH A UNIQUE SPECIFICITY FOR THE REGULATION OF REMARK 1 TITL 3 STAPHOPAINS, STAPHYLOCOCCUS SPP. CYSTEINE PROTEINASES REMARK 1 REF MOL.MICROBIOL. V. 49 1051 2003 REMARK 1 REFN ISSN 0950-382X REMARK 1 DOI 10.1046/J.1365-2958.2003.03613.X REMARK 1 REFERENCE 3 REMARK 1 AUTH I.MASSIMI,E.PARK,K.RICE,W.MULLER-ESTERL,D.SAUDER,M.J.MCGAVIN REMARK 1 TITL IDENTIFICATION OF A NOVEL MATURATION MECHANISM AND REMARK 1 TITL 2 RESTRICTED SUBSTRATE SPECIFICITY FOR THE SSPB CYSTEINE REMARK 1 TITL 3 PROTEASE OF STAPHYLOCOCCUS AUREUS REMARK 1 REF J.BIOL.CHEM. V. 277 41770 2002 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.M207162200 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 64796 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3406 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4300 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2270 REMARK 3 BIN FREE R VALUE SET COUNT : 214 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4816 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 458 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.21000 REMARK 3 B22 (A**2) : 0.36000 REMARK 3 B33 (A**2) : -0.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.123 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.117 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4867 ; 0.020 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 4032 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6610 ; 1.565 ; 1.912 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9405 ; 3.935 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 583 ; 4.644 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 698 ; 0.117 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5515 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 975 ; 0.011 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 955 ; 0.240 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4600 ; 0.310 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 2339 ; 0.115 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 383 ; 0.180 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 30 ; 0.222 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 82 ; 0.371 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 13 ; 0.206 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2921 ; 1.933 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4690 ; 3.032 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1946 ; 2.272 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1920 ; 3.473 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1PXV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-JUL-03. REMARK 100 THE DEPOSITION ID IS D_1000019681. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JAN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MPG/DESY, HAMBURG REMARK 200 BEAMLINE : BW6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.05 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 66436 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : 0.05200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.18200 REMARK 200 R SYM FOR SHELL (I) : 0.18200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP, FFFEAR REMARK 200 STARTING MODEL: 1CV8, 1NYC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2 M (NH4)2SO4 AND 5% ISOPROPANOL, 100 REMARK 280 MM GUANIDINIUM HYDROCHLORIDE, PH 6.3, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.74250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.46350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.48300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.46350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.74250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.48300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -50.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -111.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -97.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -73.48500 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 GLY C -1 REMARK 475 VAL C 109 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 PHE A 219 CG CD1 CD2 CE1 CE2 CZ REMARK 480 GLN A 314 CG CD OE1 NE2 REMARK 480 HIS B 212 CB CG ND1 CD2 CE1 NE2 REMARK 480 HIS B 213 CB CG ND1 CD2 CE1 NE2 REMARK 480 PHE B 219 CG CD1 CD2 CE1 CE2 CZ REMARK 480 GLN B 314 CG CD OE1 NE2 REMARK 480 GLN C 3 CG CD OE1 NE2 REMARK 480 ASP C 12 CG OD1 OD2 REMARK 480 THR C 13 CB OG1 CG2 REMARK 480 THR C 14 CB OG1 CG2 REMARK 480 LYS C 15 CG CD CE NZ REMARK 480 LEU C 16 CG CD1 CD2 REMARK 480 GLN D 3 CG CD OE1 NE2 REMARK 480 ASP D 12 CG OD1 OD2 REMARK 480 THR D 13 OG1 CG2 REMARK 480 THR D 14 C OG1 CG2 REMARK 480 LYS D 15 CG CD CE NZ REMARK 480 LEU D 16 CG CD1 CD2 REMARK 480 THR D 17 OG1 CG2 REMARK 480 HIS D 18 CG ND1 CD2 CE1 NE2 REMARK 480 LEU D 19 CG CD1 CD2 REMARK 480 GLU D 20 CG CD OE1 OE2 REMARK 480 GLN D 21 CG CD OE1 NE2 REMARK 480 THR D 22 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL C 109 C VAL C 109 OXT 0.177 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 238 -114.49 -111.61 REMARK 500 ALA A 283 -169.97 -104.92 REMARK 500 PHE B 238 -112.02 -110.23 REMARK 500 SER C 0 139.97 -170.40 REMARK 500 ASP C 82 -67.05 -101.86 REMARK 500 LEU C 108 -159.77 -148.90 REMARK 500 THR D 14 -7.37 -56.26 REMARK 500 ASP D 82 -75.64 -92.16 REMARK 500 LEU D 108 -166.54 -116.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 459 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 460 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 461 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 462 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 463 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GAI B 464 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NYC RELATED DB: PDB REMARK 900 FREE STAPHOSTATIN B REMARK 900 RELATED ID: 1CV8 RELATED DB: PDB REMARK 900 STAPHOPAIN A REMARK 999 REMARK 999 SEQUENCE REMARK 999 AT THE TIME OF PROCESSING, THERE WAS NO DATABASE REMARK 999 SEQUENCE AVAILABLE FOR THE PROTEINS FROM STAPHYLOCOCCUS REMARK 999 AUREUS, STRAIN V8 THAT WERE CRYSTALLIZED HERE. REMARK 999 THE CLOSEST HOMOLOGUES WITH PROTEIN SEQUENCES IN A REMARK 999 DATABASE WERE FROM STAPHYLOCOCCUS AUREUS SUBSP. REMARK 999 AUREUS MW2. THE AUTHOR CLAIMS THAT THE RESIDUE REMARK 999 CONFLICTS BETWEEN STRAIN V8 AND STRAIN MW2 REMARK 999 NOTED HERE ARE GENUINE, CONFIRMED STRAIN DIFFERENCES. DBREF 1PXV A 220 393 UNP Q70UQ8 SSPB_STAAU 220 393 DBREF 1PXV B 220 393 UNP Q70UQ8 SSPB_STAAU 220 393 DBREF 1PXV C 1 109 UNP Q9EYW6 SSPC_STAAU 1 109 DBREF 1PXV D 1 109 UNP Q9EYW6 SSPC_STAAU 1 109 SEQADV 1PXV GLY A 211 UNP Q70UQ8 CLONING ARTIFACT SEQADV 1PXV HIS A 212 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV HIS A 213 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV HIS A 214 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV HIS A 215 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV HIS A 216 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV HIS A 217 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV GLU A 218 UNP Q70UQ8 CLONING ARTIFACT SEQADV 1PXV PHE A 219 UNP Q70UQ8 CLONING ARTIFACT SEQADV 1PXV ALA A 243 UNP Q70UQ8 CYS 243 ENGINEERED MUTATION SEQADV 1PXV ALA A 283 UNP Q70UQ8 SER 283 SEE REMARK 999 SEQADV 1PXV ASN A 310 UNP Q70UQ8 GLU 310 SEE REMARK 999 SEQADV 1PXV GLY B 211 UNP Q70UQ8 CLONING ARTIFACT SEQADV 1PXV HIS B 212 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV HIS B 213 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV HIS B 214 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV HIS B 215 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV HIS B 216 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV HIS B 217 UNP Q70UQ8 EXPRESSION TAG SEQADV 1PXV GLU B 218 UNP Q70UQ8 CLONING ARTIFACT SEQADV 1PXV PHE B 219 UNP Q70UQ8 CLONING ARTIFACT SEQADV 1PXV ALA B 243 UNP Q70UQ8 CYS 243 ENGINEERED MUTATION SEQADV 1PXV ALA B 283 UNP Q70UQ8 SER 283 SEE REMARK 999 SEQADV 1PXV ASN B 310 UNP Q70UQ8 GLU 310 SEE REMARK 999 SEQADV 1PXV GLY C -1 UNP Q9EYW6 CLONING ARTIFACT SEQADV 1PXV SER C 0 UNP Q9EYW6 CLONING ARTIFACT SEQADV 1PXV PHE C 70 UNP Q9EYW6 ILE 70 SEE REMARK 999 SEQADV 1PXV GLY D -1 UNP Q9EYW6 CLONING ARTIFACT SEQADV 1PXV SER D 0 UNP Q9EYW6 CLONING ARTIFACT SEQADV 1PXV PHE D 70 UNP Q9EYW6 ILE 70 SEE REMARK 999 SEQRES 1 A 183 GLY HIS HIS HIS HIS HIS HIS GLU PHE ASP GLN VAL GLN SEQRES 2 A 183 TYR GLU ASN THR LEU LYS ASN PHE LYS ILE ARG GLU GLN SEQRES 3 A 183 GLN PHE ASP ASN SER TRP ALA ALA GLY PHE SER MET ALA SEQRES 4 A 183 ALA LEU LEU ASN ALA THR LYS ASN THR ASP THR TYR ASN SEQRES 5 A 183 ALA HIS ASP ILE MET ARG THR LEU TYR PRO GLU VAL SER SEQRES 6 A 183 GLU GLN ASP LEU PRO ASN CYS ALA THR PHE PRO ASN GLN SEQRES 7 A 183 MET ILE GLU TYR GLY LYS SER GLN GLY ARG ASP ILE HIS SEQRES 8 A 183 TYR GLN GLU GLY VAL PRO SER TYR ASN GLN VAL ASP GLN SEQRES 9 A 183 LEU THR LYS ASP ASN VAL GLY ILE MET ILE LEU ALA GLN SEQRES 10 A 183 SER VAL SER GLN ASN PRO ASN ASP PRO HIS LEU GLY HIS SEQRES 11 A 183 ALA LEU ALA VAL VAL GLY ASN ALA LYS ILE ASN ASP GLN SEQRES 12 A 183 GLU LYS LEU ILE TYR TRP ASN PRO TRP ASP THR GLU LEU SEQRES 13 A 183 SER ILE GLN ASP ALA ASP SER SER LEU LEU HIS LEU SER SEQRES 14 A 183 PHE ASN ARG ASP TYR ASN TRP TYR GLY SER MET ILE GLY SEQRES 15 A 183 TYR SEQRES 1 B 183 GLY HIS HIS HIS HIS HIS HIS GLU PHE ASP GLN VAL GLN SEQRES 2 B 183 TYR GLU ASN THR LEU LYS ASN PHE LYS ILE ARG GLU GLN SEQRES 3 B 183 GLN PHE ASP ASN SER TRP ALA ALA GLY PHE SER MET ALA SEQRES 4 B 183 ALA LEU LEU ASN ALA THR LYS ASN THR ASP THR TYR ASN SEQRES 5 B 183 ALA HIS ASP ILE MET ARG THR LEU TYR PRO GLU VAL SER SEQRES 6 B 183 GLU GLN ASP LEU PRO ASN CYS ALA THR PHE PRO ASN GLN SEQRES 7 B 183 MET ILE GLU TYR GLY LYS SER GLN GLY ARG ASP ILE HIS SEQRES 8 B 183 TYR GLN GLU GLY VAL PRO SER TYR ASN GLN VAL ASP GLN SEQRES 9 B 183 LEU THR LYS ASP ASN VAL GLY ILE MET ILE LEU ALA GLN SEQRES 10 B 183 SER VAL SER GLN ASN PRO ASN ASP PRO HIS LEU GLY HIS SEQRES 11 B 183 ALA LEU ALA VAL VAL GLY ASN ALA LYS ILE ASN ASP GLN SEQRES 12 B 183 GLU LYS LEU ILE TYR TRP ASN PRO TRP ASP THR GLU LEU SEQRES 13 B 183 SER ILE GLN ASP ALA ASP SER SER LEU LEU HIS LEU SER SEQRES 14 B 183 PHE ASN ARG ASP TYR ASN TRP TYR GLY SER MET ILE GLY SEQRES 15 B 183 TYR SEQRES 1 C 111 GLY SER MET TYR GLN LEU GLN PHE ILE ASN LEU VAL TYR SEQRES 2 C 111 ASP THR THR LYS LEU THR HIS LEU GLU GLN THR ASN ILE SEQRES 3 C 111 ASN LEU PHE ILE GLY ASN TRP SER ASN HIS GLN LEU GLN SEQRES 4 C 111 LYS SER ILE CYS ILE ARG HIS GLY ASP ASP THR SER HIS SEQRES 5 C 111 ASN GLN TYR HIS ILE LEU PHE ILE ASP THR ALA HIS GLN SEQRES 6 C 111 ARG ILE LYS PHE SER SER PHE ASP ASN GLU GLU ILE ILE SEQRES 7 C 111 TYR ILE LEU ASP TYR ASP ASP THR GLN HIS ILE LEU MET SEQRES 8 C 111 GLN THR SER SER LYS GLN GLY ILE GLY THR SER ARG PRO SEQRES 9 C 111 ILE VAL TYR GLU ARG LEU VAL SEQRES 1 D 111 GLY SER MET TYR GLN LEU GLN PHE ILE ASN LEU VAL TYR SEQRES 2 D 111 ASP THR THR LYS LEU THR HIS LEU GLU GLN THR ASN ILE SEQRES 3 D 111 ASN LEU PHE ILE GLY ASN TRP SER ASN HIS GLN LEU GLN SEQRES 4 D 111 LYS SER ILE CYS ILE ARG HIS GLY ASP ASP THR SER HIS SEQRES 5 D 111 ASN GLN TYR HIS ILE LEU PHE ILE ASP THR ALA HIS GLN SEQRES 6 D 111 ARG ILE LYS PHE SER SER PHE ASP ASN GLU GLU ILE ILE SEQRES 7 D 111 TYR ILE LEU ASP TYR ASP ASP THR GLN HIS ILE LEU MET SEQRES 8 D 111 GLN THR SER SER LYS GLN GLY ILE GLY THR SER ARG PRO SEQRES 9 D 111 ILE VAL TYR GLU ARG LEU VAL HET SO4 A 460 5 HET SO4 A 462 5 HET SO4 A 463 5 HET SO4 B 459 5 HET SO4 B 461 5 HET GAI B 464 4 HETNAM SO4 SULFATE ION HETNAM GAI GUANIDINE FORMUL 5 SO4 5(O4 S 2-) FORMUL 10 GAI C H5 N3 FORMUL 11 HOH *458(H2 O) HELIX 1 1 TRP A 242 ASN A 257 1 16 HELIX 2 2 ASN A 262 TYR A 271 1 10 HELIX 3 3 ASP A 278 CYS A 282 5 5 HELIX 4 4 PHE A 285 GLN A 296 1 12 HELIX 5 5 SER A 308 ASP A 318 1 11 HELIX 6 6 SER A 379 ASN A 381 5 3 HELIX 7 7 TRP B 242 LYS B 256 1 15 HELIX 8 8 ASN B 262 TYR B 271 1 10 HELIX 9 9 ASP B 278 CYS B 282 5 5 HELIX 10 10 PHE B 285 GLN B 296 1 12 HELIX 11 11 SER B 308 ASP B 318 1 11 HELIX 12 12 ASP C 12 LEU C 16 5 5 HELIX 13 13 THR C 17 LEU C 26 1 10 HELIX 14 14 ASP D 12 LEU D 16 5 5 HELIX 15 15 THR D 17 LEU D 26 1 10 SHEET 1 A 6 VAL A 222 THR A 227 0 SHEET 2 A 6 GLY A 339 ILE A 350 -1 O ASN A 347 N ASN A 226 SHEET 3 A 6 ILE A 322 GLN A 327 -1 N ALA A 326 O HIS A 340 SHEET 4 A 6 ARG A 382 ILE A 391 -1 O ASN A 385 N GLN A 327 SHEET 5 A 6 GLN A 353 TRP A 359 0 SHEET 6 A 6 SER A 367 ASP A 370 -1 O GLN A 369 N LEU A 356 SHEET 1 B 5 HIS A 301 GLU A 304 0 SHEET 2 B 5 ARG A 382 ILE A 391 -1 O ILE A 391 N HIS A 301 SHEET 3 B 5 ILE A 322 GLN A 327 -1 N GLN A 327 O ASN A 385 SHEET 4 B 5 GLY A 339 ILE A 350 -1 O HIS A 340 N ALA A 326 SHEET 5 B 5 LEU A 375 LEU A 378 0 SHEET 1 C 6 VAL B 222 THR B 227 0 SHEET 2 C 6 GLY B 339 ILE B 350 -1 O ASN B 347 N ASN B 226 SHEET 3 C 6 ILE B 322 SER B 328 -1 N ILE B 324 O LEU B 342 SHEET 4 C 6 ARG B 382 ILE B 391 -1 O ASN B 385 N GLN B 327 SHEET 5 C 6 GLN B 353 TRP B 359 0 SHEET 6 C 6 SER B 367 ASP B 370 -1 O GLN B 369 N LEU B 356 SHEET 1 D 5 HIS B 301 GLU B 304 0 SHEET 2 D 5 ARG B 382 ILE B 391 -1 O SER B 389 N GLN B 303 SHEET 3 D 5 ILE B 322 SER B 328 -1 N GLN B 327 O ASN B 385 SHEET 4 D 5 GLY B 339 ILE B 350 -1 O LEU B 342 N ILE B 324 SHEET 5 D 5 LEU B 375 LEU B 378 0 SHEET 1 E 9 GLN C 3 VAL C 10 0 SHEET 2 E 9 LYS C 38 HIS C 44 1 O CYS C 41 N ILE C 7 SHEET 3 E 9 GLY C 29 ASN C 33 -1 N TRP C 31 O ILE C 40 SHEET 4 E 9 ILE C 103 ARG C 107 -1 O GLU C 106 N SER C 32 SHEET 5 E 9 HIS C 86 SER C 93 -1 N ILE C 87 O TYR C 105 SHEET 6 E 9 ASN C 72 ASP C 83 -1 N ILE C 78 O GLN C 90 SHEET 7 E 9 ARG C 64 SER C 69 -1 N PHE C 67 O TYR C 77 SHEET 8 E 9 GLN C 52 ASP C 59 -1 N ASP C 59 O ARG C 64 SHEET 9 E 9 GLN C 3 VAL C 10 1 N VAL C 10 O TYR C 53 SHEET 1 F 9 GLN D 3 VAL D 10 0 SHEET 2 F 9 LYS D 38 HIS D 44 1 O ARG D 43 N LEU D 9 SHEET 3 F 9 GLY D 29 ASN D 33 -1 N ASN D 33 O LYS D 38 SHEET 4 F 9 ILE D 103 ARG D 107 -1 O GLU D 106 N SER D 32 SHEET 5 F 9 HIS D 86 SER D 93 -1 N ILE D 87 O TYR D 105 SHEET 6 F 9 ASN D 72 ASP D 83 -1 N ILE D 78 O GLN D 90 SHEET 7 F 9 ARG D 64 SER D 69 -1 N PHE D 67 O TYR D 77 SHEET 8 F 9 GLN D 52 ASP D 59 -1 N ASP D 59 O ARG D 64 SHEET 9 F 9 GLN D 3 VAL D 10 1 N VAL D 10 O TYR D 53 SITE 1 AC1 5 HOH A 606 LYS B 232 ARG B 234 HOH B 576 SITE 2 AC1 5 HOH B 590 SITE 1 AC2 2 LYS A 232 ARG A 234 SITE 1 AC3 7 ASN B 381 ARG B 382 ASP B 383 HOH B 541 SITE 2 AC3 7 HOH B 626 HIS D 62 ARG D 64 SITE 1 AC4 4 ARG A 382 ASP A 383 HIS C 62 ARG C 64 SITE 1 AC5 7 HIS A 213 HIS A 214 HIS A 215 HIS A 217 SITE 2 AC5 7 HIS B 213 HIS B 215 HIS B 217 SITE 1 AC6 2 GLU A 291 LYS A 294 CRYST1 73.485 94.966 110.927 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013608 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010530 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009015 0.00000